Abstract
Introduction

Previous reports have described patients with a malignant pheochromocytoma who developed distant metastasis several years after resection (1, 2). A malignant pheochromocytoma is rare, and an effective therapy for metastasis and/or recurrence has not been established. We successfully treated a case of liver metastasis using transcatheter arterial chemoembolization (TACE) in a patient who previously underwent resection for pheochromocytoma and was diagnosed as benign.
Case Report
A 76-year-old woman had been treated for hypertension with anti-hypertensive agents for 10 years. An examination found an abdominal mass and she was admitted to our hospital, where computed tomography (CT) revealed a right adrenal gland tumor (13 cm (Fig. 4c) .
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T a b l e 1 . L a b o r a t o r y Da t a o n Ad mi s s i o n
To prevent hypertensive crisis following angiography, we changed the hypertensive agents from candesartan (ARB) and benidipine hydrochloride (Ca antagonist) to doxazosin (α blocker) after admission, with the dose of doxazosin
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gradually increased (8 mg T a b l e 4 . L i t e r a t u r e o n P h e o c h r o mo c y t o ma wi t h L i v e r Me t a s t a s i completely resected (13, 14) . TACE is widely used for patients with unresectable hepatocellular carcinoma (HCC) and it is reported to improve the survival rate of affected patients (15, 16 
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